← Back to catalogue

Dolphin/IQ, Dolphin/4D, Dolphin/MAX with Dolphin/XF Robot Accessory

FDA 510(k)FDA UDIEUDAMED

Class II (US FDA 510(k))

510(k) K202742Ref PVC0227Model Dolphin product family – Transcranial Doppler systemsRef PVC0200

by Viasonix Ltd

Identity

Trade Name
Dolphin/MAX EUDAMED
Dolphin/IQ EUDAMED
Dolphin FDA UDI
Generic Name
General-purpose ultrasound imaging system FDA UDI
Device Name
Dolphin/IQ EUDAMED
The Dolphin/IQ is a medical Doppler device intended for noninvasive measurements of blood flow velocities in arteries and veins in adults and Pediatric. The Dolphin/IQ system can be used in hospitals, clinics and physician offices FDA UDI
The Dolphin/MAX is a medical Doppler device intended for noninvasive measurements of blood flow velocities in arteries and veins in adults and Pediatric. The Dolphin/MAX system can be used in hospitals, clinics and physician offices FDA UDI
Model / Reference
Dolphin product family – Transcranial Doppler systems EUDAMED
PVC0227 EUDAMED
PVC0200 EUDAMED
IQ FDA UDI
MAX FDA UDI
Description
The Dolphin/IQ is a medical Doppler device intended for noninvasive measurements of blood flow velocities in arteries and veins in adults and Pediatric. The Dolphin/IQ system can be used in hospitals, clinics and physician offices FDA UDI
The Dolphin/MAX is a medical Doppler device intended for noninvasive measurements of blood flow velocities in arteries and veins in adults and Pediatric. The Dolphin/MAX system can be used in hospitals, clinics and physician offices FDA UDI

Identifiers

Primary DI / UDI-DI
07290016880328 EUDAMEDFDA UDI
07290016880212 EUDAMEDFDA UDI
Basic UDI-DI
729001688034CJ EUDAMED
510(k) Number
K202742 FDA 510(k)
K191023 FDA UDI
FDA Product Code
IYN FDA 510(k)FDA UDI
ITX FDA UDI
EMDN Code
Z11040103 PORTABLE ULTRASOUND SCANNERS EUDAMED
GMDN Term
General-purpose ultrasound imaging system FDA UDI

Classification

Device Class
Class IIa EUDAMED
Class II FDA 510(k)FDA UDI
Legislation / Framework
21 CFR Part 892.1550 FDA 510(k)
Regulation Number
892.1550 FDA 510(k)FDA UDI
892.1570 FDA UDI
Market of Registration
Poland EUDAMED
Germany EUDAMED
Advisory Committee
Radiology FDA 510(k)
FDA Decision
SESE Substantially Equivalent FDA 510(k)
Commercial Distribution
Not in Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

EUDAMEDFDA UDI

Single Use

No

FDA UDI

Implantable

No

EUDAMEDFDA UDI

Reusable

No

EUDAMED

Contains Latex

No

EUDAMEDFDA UDI

Reprocessed

No

EUDAMED

CMR Substance

No

EUDAMED

Human-derived

No

EUDAMED

Human Tissues

No

EUDAMED

Animal Tissues

No

EUDAMED

Endocrine Disruptor

No

EUDAMED

Administering Medicine

No

EUDAMED

Measuring Function

No

EUDAMED

Incorporates Medicinal Product

No

EUDAMED

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

No

FDA UDI

Serial Number

Yes

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

Yes

FDA UDI

The Dolphin/IQ, Dolphin/4D, and Dolphin/MAX are Transcranial Doppler (TCD) devices designed for noninvasive measurement of blood flow velocities in cerebral arteries and veins. These systems utilize ultrasound technology to assess cerebral hemodynamics, supporting clinical evaluations of conditions such as stroke risk, vasospasm, and intracranial pressure monitoring in both adult and pediatric patients.

The devices are supplied as standalone modules or paired with the Dolphin/XF robotic probe accessory for automated scanning. They are intended for single-use or reusable applications, depending on the model and configuration, and are regulated under FDA 510(k) clearance and MDR compliance. The Dolphin/XF robotic accessory enhances probe stability and reduces operator fatigue during prolonged monitoring sessions, with no specific MRI safety restrictions stated.

Frequently asked questions

What clinical conditions can the Dolphin/IQ, Dolphin/4D, and Dolphin/MAX devices help evaluate using ultrasound technology?

These devices are designed to measure blood flow velocities in cerebral arteries and veins, which helps clinicians assess conditions like stroke risk, vasospasm (narrowing of blood vessels in the brain), and intracranial pressure. By providing real-time cerebral hemodynamics data, they support evaluations in both adult and pediatric patients during critical monitoring.

How does the Dolphin/XF robotic accessory improve the user experience during prolonged monitoring sessions?

The Dolphin/XF robotic accessory is paired with the Dolphin/IQ, Dolphin/4D, or Dolphin/MAX to automate probe positioning, reducing operator fatigue and enhancing stability during extended scans. This feature ensures consistent probe placement, which is particularly useful in long-term monitoring where precision matters.

Are these devices intended for single-use or reusable applications, and how does that affect their clinical workflow?

The Dolphin/IQ, Dolphin/4D, and Dolphin/MAX can be used either as single-use or reusable devices, depending on the specific model and configuration. This flexibility allows clinicians to choose based on infection control protocols, patient volume, and workflow efficiency—whether they prioritize convenience of single-use or cost savings with reusable components.

What regulatory pathways have these devices undergone, and which advisory committee was involved in their evaluation?

The Dolphin/IQ, Dolphin/4D, and Dolphin/MAX devices, including the Dolphin/XF robotic accessory, were cleared under the FDA’s 510(k) pathway with a Traditional review and classified under the Radiology advisory committee (RA). They also comply with the Medical Device Regulation (MDR) in their respective markets, ensuring adherence to both U.S. and EU standards.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them. Sources consulted: Dolphin/IQ - High End TCD Module by Viasonix, Dolphin/MAX - Transcranial Doppler (TCD) Machine by Viasonix, Dolphin/IQ, Dolphin/4D and Dolphin/MAX with Dolphin/XF robot accessory

Authorization Coverage (2 countries)

Regulatory Authorizations

European Union Active

MDR

United States Active

FDA_510K

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Viasonix Ltd
FDA Applicant
Viasonix , Ltd.

Sources (5)

  • FDA 510(k) K202742 24 fields · synced Sep 18, 2026
  • FDA UDI 562e3cb8-1d55-47a2-9159-d2d163cb7c6b 35 fields · synced May 26, 2026
  • FDA UDI a4b2c405-7b12-4108-b551-e50002f4b9c2 35 fields · synced May 30, 2026
  • EUDAMED 7e666159-4491-4232-baf2-6a93b27d7b29 61 fields · synced Jul 11, 2026
  • EUDAMED 2ebeff31-0ce5-4703-b7f5-baff2d6626eb 61 fields · synced Jul 27, 2026